PD-1 (clone Pembrolizumab) (clone ), anti-human antibody
€445.00
In stock
SKU
AC-ABV12037-100
Catalog Number: AC-ABV12037-100
Size: 100 µg
Host: Human IgG
Applications: E
Datasheet
Request Information
Size: 100 µg
Host: Human IgG
Applications: E
Datasheet
Request Information
Background:
Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells.
Other Names:
Keytruda, PD-1
Primary Accession: Q02242
Gene Name: Pdcd1 {ECO:0000312|MGI:MGI:104879}
Gene ID: 18566
Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells.
Other Names:
Keytruda, PD-1
Primary Accession: Q02242
Gene Name: Pdcd1 {ECO:0000312|MGI:MGI:104879}
Gene ID: 18566
| Is Featured? | No |
|---|
Write Your Own Review